Hence, we have analyzed 12 premalignant lesions (1 ADH and 11 DCIS) and found concomitant methylation of RASSF1A and SFRP1 in 10 of these 12 samples. The gene discussed is SFRP1; the disease is ductal breast carcinoma in situ.